backtop


Print

The weekly injection removed 80 percent of senile plaques that cause Alzheimer's

Canadian researchers have come one giant step closer to finding treatment for those with Alzheimer's disease, and even a preventative vaccine.

The team of researchers hail from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK), and was led by Dr. Serge Rivest, professor at Université Laval's Faculty of Medicine and researcher at the CHU de Québec research center.

A key part of Alzheimer's disease is the production of a toxic molecule called amyloid beta. The body's defenders, called microglial cells, cannot eliminate amyloid beta, and that's when senile plaques are formed.

But the new study gives the brain's immune cells a boost through monophosphoryl lipid A, called MPL, which is a vaccine that has already been proven safe through its use with GSK.

After giving mice with Alzheimer's symptoms weekly injections of MPL for 12 weeks, about 80 percent of senile plaques were eliminated. Also, the mice showed improvement in cognitive function.

According to the team, the MPL injection could not only slow the progression of the disease in patients already showing symptoms, but also be used as a preventative vaccine for those at risk.

Last September, the cancer drugs erlotinib (Tarceva) and gefitinib (Iressa) were used to cure Alzheimer's in fruit flies and rats.

Source: Science Daily





“We do believe we have a moral responsibility to keep porn off the iPhone.” -- Steve Jobs






Most Popular ArticlesThings that Apple didn’t tell about iPhone X
November 13, 2017, 6:20 AM
Samsung Flip Phone W2018 – Leaked
November 12, 2017, 7:40 AM
Gigabyte GA-Z270-Gaming K3 – With Smart Fan 5
November 13, 2017, 6:55 AM
HTC VR – Stand Alone VR may China November 14th.
November 5, 2017, 7:00 AM
Galaxy S8 Infinitely Amazing
November 4, 2017, 5:58 AM







botimage
Copyright 2017 DailyTech LLC. - RSS Feed | Advertise | About Us | Ethics | FAQ | Terms, Conditions & Privacy Information | Kristopher Kubicki